Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01GlobeNewsWire · 4 days ago
Evaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01GlobeNewsWire · Oct 19, 2026
These 3 ETFs Could Benefit From the Parts of Inflation That Won't Go AwayMarketBeat · Oct 8, 2026
Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual MeetingGlobeNewsWire · Oct 2, 2026
Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine programGlobeNewsWire · Aug 17, 2026The VanEck Environmental Services ETF (EVX) aims to closely mirror the price and yield performance of the MarketVector Global Environmental Services Index (MVEVX), before accounting for its own fees and expenses. This index tracks companies primarily involved in various environmental services, including environmental consulting and modeling, wastewater and drainage management, general waste disposal, environmental remediation and protection, non-industrial air filtration, and technologies for carbon capture, waste-to-energy, and biofuel production, though it excludes certain recycling activities.